PDEX Stock Price, Analysis & Fundamentals

Analysis

Pro-Dex, Inc. is a healthcare company operating in the medical instruments and supplies industry. The company has a market capitalization of $127.00 million, revenue of $70.23 million on a trailing twelve-month basis, and employs 179 individuals. Financially, Pro-Dex has demonstrated profitability with gross, operating, and profit margins of 28.1%, 16.8%, and 15.9% respectively. The company's returns on equity and assets are 30.9% and 11.4%. On the balance sheet side, Pro-Dex has debt of $14.30 million and cash reserves of $10.55 million, resulting in a debt-to-equity ratio of 34.46. Pro-Dex's valuation is characterized by a price-to-earnings ratio of 11.35 on a trailing twelve-month basis and 18.80 on a forward basis. The company has experienced revenue growth of 24.4% year-over-year, while earnings have grown at an even faster rate of 86.7%.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Pro-Dex, Inc.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Visit website →

PDEX

Price History (1Y)

Analysis

About Pro-Dex, Inc.

Key Statistics

Company Info